Exhibition Review||MEDICA ——Where healthcare is going!
November 14-17, 2022
The 54th MEDICA
Grandly held in Dusseldorf, Germany!
As a world-renowned comprehensive medical exhibition, MEDICA is recognized as the largest hospital and medical equipment exhibition in the world and ranks first in the world’s medical trade exhibitions with its irreplaceable scale and influence. In this exhibition, more than 5,000 well-known companies from all over the world gathered to display more than 10,000 products.
Triplex International Biosciences (China) Co., LTD(TIB) brought dozens of products to booth 17E34-2 at this exhibition!
TIB is a biomedical high-tech enterprise integrating the R&D, production and sales of immunodiagnostic reagents, molecular diagnostic reagents and pathological diagnostic reagents, as well as national chain medical testing services. After 18 years of struggle, the company has formed an organic closed industrial chain consisting of research and development, production, sales services, and medical testing laboratories. These links restrict and promote each other to build a big health industry ecosystem.
THREE MAJOR AREAS OF WONDERFUL DISPLAY
In the field of immunodiagnosis, the rapid detection series developed and produced by TIB is mainly used for the detection of influenza A/B virus, SARS-Cov-2/COVID-19, malaria, dengue fever, cholera, etc. Committed to providing customers with professional rapid diagnosis services.
Molecular diagnostic products use fluorescent PCR technology to hatch group B streptococcus (GBS), human papillomavirus (HPV), coronavirus (SARS-CoV-2), hepatitis virus (HBV/HCV), sexually transmitted bacteria and Infectious fungi series and other testing products. After decades of market testing, it has stable customers and sales channels and enjoys a good industry reputation.
After 18 years of continuous R&D and upgrading, liquid-based cytology technology in the field of pathological diagnosis has become a leader in the field of cytopathology in China. Among them, the liquid-based cell film production and staining system together with the intelligent film reading and diagnosis system constitute a whole-process solution for cervical cancer screening, which helps public health manage the cervical cancer prevention and control system.
